What You Should Know:
- Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
- The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development.
A Powerful Collaboration
Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Stakeholders Urge Congress and White House to Maintain Remote Prescribing Flexibilities
What You Should Know:
- Over 330 stakeholder organizations have joined forces to call on Congress and the White House to intervene and ensure ongoing access to remote prescribing of controlled substances.
- Led by the American Telemedicine Association (ATA) and ATA Action, these organizations are concerned about the potential for the Drug Enforcement Administration (DEA) to significantly limit virtual prescribing, either through new regulations or by allowing existing
Read More
AI Shows Promise in Early Lung Cancer Detection via Chest X-rays
What You Should Know:
- A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.
- Researchers at Phrapokklao Hospital's Cancer Centre of Excellence in Bangkok, Thailand, used an AI-powered chest X-ray interpretation tool (qXR from Qure.ai) and found promising initial results.
Early Detection is Key
Lung cancer has one of the
Read More
Study Reveals AI Predicts Patient Risk in Polypharmacy Seniors
What You Should Know:
- A new study published in The American Journal of Managed Care (AJMC) highlights the potential of AI-powered technology to address the complex issue of polypharmacy in senior patients.
- The study, conducted by researchers at Brigham and Women’s Hospital, evaluated FeelBetter’s platform and found it to be highly effective in predicting medication risks and stratifying patients based on their likelihood of hospitalization or emergency department visits.
The
Read More
Former FDA/Verily’s Amy Abernethy Launches Highlander Health
What You Should Know:
- Industry veterans Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D., have co-founded Highlander Health, a new company dedicated to improving individualized patient care.
- The company is comprised of Highlander Health Institute, a public interest platform, and Highlander Health Partners, an investment arm.
A Vision for Personalized Healthcare
Dr. Abernethy and Dr. Hirsch believe that the healthcare industry needs a more integrated approach to
Read More
Hinge Health Launches Enso 3: A New FDA-Cleared Device for Chronic Pain
What You Should Know:
Today, Hinge Health is announcing Enso 3™, a patented, wireless device that is FDA-cleared and clinically-proven to reduce musculoskeletal pain. One in four people with chronic pain experience sudden spikes that often disrupt their daily activities and compel them to seek relief.The new Enso 3 delivers electrical nerve stimulation that achieves non-invasive, non-addictive pain relief within minutes. First shipments of the new Enso are starting this month, with wider
Read More
Ubie’s AI Symptom Checker Outperforms Traditional Methods
What You Should Know:
Ubie, a global healthcare AI platform that enhances the intersection of patients, providers, and life sciences, today announced data from Ubie Symptom Checker: A Clinical Vignette Simulation Study, which was published on medRxiv.The study evaluated the performance of Ubie’s platform using an innovative large language model-assisted (LLM) simulation method. Results show that Ubie achieved a Top-5 hit (inclusion of the correct diagnosis) accuracy of 63.4% and a
Read More
Essence SmartCare, Skyresponse Partner to Expand Ageing-In-Place Products Across Europe
What You Should Know:
Essence SmartCare, part of Essence Group, a global leader in IoT remote care solutions, today announced the integration of Care@Home, an end-to-end senior care solution, with leading Swedish alarm management platform Skyresponse.Under this partnership, over two million seniors across the UK, Switzerland, Nordic countries, and the DACH region will have expanded access to Care@Home, providing a fully connected care experience from initial assessment to ongoing monitoring
Read More
American Cancer Society and Yosemite Award $6M in Research Grants to Innovate Cancer Scientists
What You Should Know:
The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from institutions across the country and are poised to make an impact in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare
Read More
Guardant Health Gemelli to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
What You Should Know:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing service as a part of its diagnostics services within its hospital system. Leveraging Guardant Health’s cutting-edge proprietary digital sequencing platform, this initiative will include on-site analysis of Guardant360® CDx liquid
Read More
